Top 25 Cardiologists to Follow on LinkedIn in 2026
Dr. Dereck Mush, MD, MBA
Caristo Diagnostics
Measures coronary inflammation from CT scans to predict future cardiovascular events.
What they do
Develops advanced coronary imaging software that identifies vascular inflammation from routine CT scans. The technology generates a cardiovascular risk score, enabling preventive therapy decisions for patients who otherwise show no signs of coronary narrowing.
The record
- Vertical
- Cardiovascular
- Sub-segment
- Cardiovascular imaging AI
- Product type
- Software as a medical device
- Stage
- Series B
- Headquarters
- Oxford, United Kingdom
- Region
- Europe
- Founded
- 2018
- Total funding
- $40M raised
Notable investors: Oxford Science Enterprises, BGF, Longwall Venture Partners.
Also in Cardiovascular
Related on The Signal
Dr. Dereck Mush, MD, MBA
The Coronary Plaque Reimbursement Playbook: Inside Elucid's $55M Raise and the Economics of Non-Invasive Cardiovascular AI
Dr. Dereck Mush, MD, MBA
Menopause benefits are expanding past hot flashes into cardiovascular and bone health
Dr. Dereck Mush, MD, MBA
The AI ECG Cardiology Market After Queen of Hearts: Who the De Novo Clearance Actually Benefits
Dr. Dereck Mush, MD, MBA